T 0282/25 (TRL agonist/LELAND STANFORD JUNIOR UNIVERSITY) of 21.05.2026
- European Case Law Identifier
- ECLI:EP:BA:2026:T028225.20260521
- Date of decision
- 21 May 2026
- Case number
- T 0282/25
- Online on
- 28 May 2026
- Petition for review of
- -
- Application number
- 19197485.6
- IPC class
- A61K 45/06C07K 16/18C07K 16/28A61K 31/519A61K 39/39A61K 31/713A61K 35/15A61P 35/00A61P 7/00A61K 31/4745A61K 39/395
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- TRL agonist
- Applicant name
- The Board of Trustees of the Leland Stanford
Junior University - Opponent name
- Genmab A/S
Pfizer Inc. - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 113(2)
- Keywords
- Basis of decision - text or agreement to text withdrawn by patent proprietor
Basis of decision - patent revoked - Catchword
- -
- Cited cases
- T 0073/84
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.